<DOC>
	<DOCNO>NCT01761487</DOCNO>
	<brief_summary>There urgent need control current national outbreak Carbapenem-resistent Klebsiella pneumonia ( CRKP ) . In Israel , death rate among CRKP carrier 3.5 time higher Carbapenem-sensitive Klebsiella pneumonia carrier ( 44 % vs. 12.5 % , respectively ) . In investigator ' previous study : A Randomized , Double-Blind , Placebo-Controlled Trial Selective Digestive Decontamination ( SDD ) Using Oral Gentamicin Oral Polymyxin E Eradication CRKP Carriage ( Infect Control Hosp Epidemiol . 2012 ; 33:14-19 ) investigator show investigator ' SDD regimen effective decolonization patient colonize CRKP . The investigator ' assumption higher dose polymyxin E together gentamicin ( SDD drug ) prolong period need overcome likelihood high rate drug inactivation gut , thereby reach CRKP carriage eradication .</brief_summary>
	<brief_title>SDD Eradicating CRKP Carriage</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Klebsiella Infections</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>Provide sigh dated write informed consent document indicate subject ( legally accept representative ) inform pertinent aspect study Hospitalized men woman least 18 year age Rectal swab culture positive CRKP last week Will willing initiate remain treatment , except adverse event occur Age le 18 year . Pregnant woman , lactate woman . A know allergy one study drug . Renal failure creatinine clearance less 50mL/min . Current Treatment IV gentamicin and/or IV polymyxin E Any safety , behavioral , clinical , administrative reason , Investigator 's judgment , would potentially compromise study compliance ability evaluate safety/efficacy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>